Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.

Saved in:
Bibliographic Details
Title: Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.
Authors: Ielpo S; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Barberini F; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Gaiba A; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Baronti C; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Greppi M; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Obino V; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy., Ravera S; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.; IRCCS AOM (Azienda Ospedaliera Metropolitana), Genoa, Italy., Bussola N; Icahn School of Medicine at Mount Sinai, New York, NY, USA., De Ninno A; Institute for Photonics and Nanotechnology, Italian National Research Council, Rome, Italy., Businaro L; Institute for Photonics and Nanotechnology, Italian National Research Council, Rome, Italy., Mussi V; Institute for Microelectronics and Microsystems, Italian National Research Council, Rome, Italy., Pomella S; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.; Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Agolini E; Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Benvenuto M; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Focaccetti C; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Marcenaro E; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy. Emanuela.Marcenaro@unige.it.; IRCCS AOM (Azienda Ospedaliera Metropolitana), Genoa, Italy. Emanuela.Marcenaro@unige.it., Bei R; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Barillari G; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Pesce S; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy. silvia.pesce@unige.it.; IRCCS AOM (Azienda Ospedaliera Metropolitana), Genoa, Italy. silvia.pesce@unige.it., Cifaldi L; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy., Melaiu O; Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy. Ombretta.Melaiu@uniroma2.it.; Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy. Ombretta.Melaiu@uniroma2.it.
Source: Cell death discovery [Cell Death Discov] 2026 Mar 27; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2058-7716
DOI:10.1038/s41420-026-03063-5